DKSH

HELM AG is a Hamburg-based family company established in 1900. HELM is one of the world’s largest independent chemicals marketing companies. The Company secures access to the world’s key markets through its specific regional knowledge and over 100 branches, sales offices and participations in over 30 countries. As a multifunctional marketing organisation HELM is active in the chemicals industry (Feedstocks and Derivatives), in the crop protection industry, pharmaceuticals and in the fertilizer industry. Our services range from international marketing, distribution, logistics, production and project development to scientific and technical services.

HELM – local, regional, global and supportive in every way

Today, 1,621 employees have found their professional home within the many and various tasks, facets and functions we offer at HELM. The combination of being a well-established global company with a great network and enabling the personal contact all over the world guarantees customer proximity and optimum service. Integrating the local expertise of our employees in the corporate set framework, we create global synergies and are in a constant process of exchanging knowledge and improving in consequence. In our corporate culture we act based on our values given by being a family company: We give guidance and direction, when it´s needed; but in general, we support our employees to challenge their sphere of influence according to the company´s best interest.

If you are interested in more detailed information about HELM please visit our website https://www.helmag.com

Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.

For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Quality Assistance S.A. is an expert for the development of:
- Biologics (monoclonal antibodies, ADCs, proteins)
- New Chemical Entities, oligonucleotides, peptides
- Nanomedicine products
- Vaccines
- Cell-Based and Gene Therapy Medicinal Products

The company holds a unique position on the market with:
All its laboratories on one site (Donstiennes, Belgium)
- Bioanalysis (PK/TK/Immuno)
- Bioassays
- Biochemistry
- Chromatography
- Elemental Impurities
- Mass Spectrometry
- Microbiology
- Molecular Biology
- Protein Characterisation
200 highly qualified professionals
more than 35 years’ expertise at the forefront of analytical sciences.

Our core competencies are:
QUALITY (CMC)
- Development and validation of analytical methods
- Characterisation
- Stability studies
- Batch (release) testing
SAFETY/EFFICACY (Bioanalysis)
- Development and validation of bioanalytical methods
- PK/TK studies
- Immunogenicity studies
- Biomarker studies

The Quality Assistance environment is GMP, GLP and GCLP/GCP compliant.

Visit www.quality-assistance.com for more information

Adaltis S.r.l. is an international IVD company headquartered in Rome, Italy.

Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases and measure human hormone responses.

http://www.adaltis.net/products/

Personal LAB - fully automated 2 plate microELISA/IFA analyser
NEXgen - fully automated 7 plate microELISA / IFA analyser
EXTRAlab - Robotic systems for liquid handling, extraction/purification of nucleic acids
Pchem Family - clinical chemistry systems for 120-500 tests/hour
(Instruments and dedicated reagents).
HEMO One - Point of Care Analyser (Diabetes / Vitamin deficiencies / Metabolic disorders / Inflammatory diseases)

With more than 10 thousands of instruments installed worldwide, Adaltis is known for excellence in performance and innovation.

Adaltis’ development and production of reagents include a wide range of assays:
- Diagnostic kits for detection of infection agents by real-time PCR (MOLgen Line)
- MicroELISA kits (EIAgen)
- Clinical Chemistry / Turbidity / Latex (CHEMgen)
- Genomics & Bioinformatics

MDx kits and reagents for DNA/RNA complete extraction kits providing a wide range of clinical specimens (liquids, tissue, cells etc.), compatible with most DNA extraction kits on market.

Adaltis provides:
Dedicated Customized Services and Antibody Production.
Adaltis has a strong record in OEM / ODM development and production of systems and kits. Well known partners have experienced and enjoy the expertise and quality products of Adaltis.

Adaltis is ISO 9001 and ISO 13485 certified. Our products are IVD-CE marked.

All of our products are backed by dedicated application support and technical service.

Customer Care Center:
info@adaltis.net

Sales and Marketing Office:
sales@adaltis.net

Order Handling and Logistics:
order@adaltis.net

Tel: + 39 0774 5791

AmeRuss Clinical Trials, LLC (headquartered in the US, Arizona) is a next generation CRO that provides comprehensive integrated clinical development solutions to Pharma, Biotech and Medical Device companies.

AmeRuss successfully operates in Russia, CIS, Baltic States, Europe, Caucasia and MENA countries.

We have the capability to conduct full service clinical trials from phase I to phase IV (including observational NIS, registries, Investigator Initiated Studies) and bring the highest quality standards at every step of the trial: protocol design, monitoring, project management, data management, statistical analysis, QA, Pharmacovigilance, Clinical Logistics, GCP trainings, publications, etc.

As a sponsor, you can expect a deep personal attention, flexible approach and a high quality work done within tough timelines.

AmeRuss is a ISO 9001-2008 certified company, and acts in accordance with the international standards and guidance such as ICH GCP, ISO 14155:2011 and other local regulatory requirements.

Please, visit us at:
www.ameruss.com

APR is a Swiss independent pharma company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases.

APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management.

A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases.

Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.